Analysis of the EGFR TKI sensitivity mutations in Tunisian NSCLC patients showed variable frequencies, depending on the number of analyzed samples, the patient’s selection criteria (clinical and pathological), and the used mutational analysis technique. This evidence concerns the gene EGFR and non-small cell lung carcinoma.